HRA
  >  
Insights
  >  
Reports And Whitepapers
  >  
Healthcare Reform in the Hospital: Implications for the Pharmaceutical, Biotech, and Medical Device Industries
Healthcare Reform in the Hospital: Implications for the Pharmaceutical, Biotech, and Medical Device Industries
March 2012
An exploration of the practical implications of healthcare reform.




Even if the PPACA – or components of it – are overturned by the U.S. Supreme Court … in the words of one of our Key Opinion Leader respondents, “the hospitals have moved too far forward to go back.”

The hospital channel is among the first to feel the immediate impact of the Patient Protection and Affordable Care Act (PPACA). Changes to hospital reimbursement paradigms to reward or penalize based on quality are generating significant implications on hospital structure, operations, and policies – driving the need for new strategies and areas of focus among pharmaceutical, biotech, and device companies vying for market share in this space.

HRA’s Healthcare Reform in the Hospital provides a complete and robust research based perspective on the issues shaping the future of this market:
Value-based purchasing, penalties for excees hospital readmissions, penalities for hospital-acquired conditions, bundled medicare payments, hospital's role in MCOs

Research Topics
  • Actions hospitals have taken, and plan for, to prepare for change under Healthcare Reform
  • Prioritization of the tenets of Value Based Purchasing
  • How hospitals are balancing conflicting needs to reduce length of stay while mitigating risks for readmission
  • Importance of Healthcare Reform to hospital policy and decision-making
  • Key influencers, and implementers of reformrelated policy
  • Hospitals’ interest in, and participation in ACOs
  • Differences in approach and effectiveness across hospital types and demographics (e.g., system affiliations, geography, size, DSH status, for profit/non-profit status, hospital philosophy, and more )
  • Unmet needs of hospitals in light of Healthcare Reform
  • The role of the Hospitalist, Director of Pharmacy, Administrator, and various committees in affecting change at the hospital
  • And more…

Applications
  • Formulate and execute strategies relative to hospitals’ evolving business paradigms resulting from Healthcare Reform
  • Leverage current and emerging decisionmakers in the hospital for more targeted promotion of products and services
  • Differentiate hospital needs, vis-à-vis Reform, based on hospital  type and level of affiliation in systems
  • Ultimately forge stronger partnerships with hospitals and hospital systems

Healthcare Reform in the Hospital is powered by robust, cross-stakeholder primary market research, including the perspectives of Directors of Pharmacy, Hospital Administrators, Hospitalists, and Key Opinion Leaders from both stand-alone institutions and hospitals that are part of a system.
Search Reports
Filter Results
 
400 Lanidex Plaza
Parsippany, NJ 07054 (973) 240-1200
Privacy Policy